Lupus Clinical Trials in Columbus, OH

10 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN	—	GlaxoSmithKline	<1 mi
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants	Phase 1	GlaxoSmithKline	<1 mi
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus	Phase 2/3	Biogen	<1 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	<1 mi
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study	Phase 2	Children's Hospital Medical Center, Cincinnati	<1 mi
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants	Phase 3	AstraZeneca	<1 mi
BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus	Phase 1	Luminary Therapeutics	<1 mi
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine	Phase 2	State University of New York - Upstate Medical University	<1 mi
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial	Phase 4	NephroNet, Inc.	<1 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer	Phase 1	National Cancer Institute (NCI)	<1 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.